RT Journal Article
SR Electronic
T1 The role of GLP-1 receptor agonists in managing type 2 diabetes
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 457
OP 464
DO 10.3949/ccjm.89a.21110
VO 89
IS 8
A1 Nachawi, Noura
A1 Rao, Pratibha PR
A1 Makin, Vinni
YR 2022
UL http://www.ccjm.org/content/89/8/457.abstract
AB Glucagon-like peptide-1 (GLP-1) receptor agonists improve glycemic control in patients with type 2 diabetes mellitus, have cardioprotective and renoprotective effects, and do not cause weight gain or significant hypoglycemia. In fact, they have been found to be effective for weight loss in patients with obesity with and without diabetes. They are now the preferred drugs to add to the regimen when oral metformin by itself is not enough to meet the patient’s hemoglobin A1c goal.